Star Equity Holdings, Inc. (STRR)
USD 1.93
(7.18%)
USD 1.93
(7.18%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 7.42 USD | 72.5% |
| 2022 | -0.36 USD | 79.55% |
| 2021 | -1.76 USD | -22.22% |
| 2020 | -1.44 USD | 40.0% |
| 2019 | -2.40 USD | -748.65% |
| 2018 | 0.37 USD | 102.07% |
| 2017 | -17.87 USD | -344.79% |
| 2016 | 7.30 USD | -35.4% |
| 2015 | 11.30 USD | 769.23% |
| 2014 | 1.30 USD | 1200.0% |
| 2013 | 0.10 USD | 103.85% |
| 2012 | -2.60 USD | -48.57% |
| 2011 | -1.75 USD | 47.13% |
| 2010 | -3.31 USD | -1203.33% |
| 2009 | 0.30 USD | 108.29% |
| 2008 | -3.62 USD | -395.89% |
| 2007 | -0.73 USD | 78.21% |
| 2006 | -3.35 USD | 35.7% |
| 2005 | -5.21 USD | -5310.0% |
| 2004 | 0.10 USD | 100.01% |
| 2003 | -1069.58 USD | 72.74% |
| 2002 | -3923.73 USD | 35.86% |
| 2001 | -6116.98 USD | -47.75% |
| 2000 | -4140.09 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.14 USD | -227.27% |
| 2024 Q2 | -1.19 USD | -857.14% |
| 2023 Q4 | 0.11 USD | 164.71% |
| 2023 Q3 | -0.17 USD | -110.49% |
| 2023 FY | - USD | 72.5% |
| 2023 Q1 | -0.00 USD | -103.79% |
| 2023 Q2 | 1.62 USD | 46385.71% |
| 2022 FY | - USD | 79.55% |
| 2022 Q1 | -0.29 USD | 65.48% |
| 2022 Q2 | -0.13 USD | 55.17% |
| 2022 Q3 | -0.12 USD | 7.69% |
| 2022 Q4 | 0.09 USD | 177.0% |
| 2021 Q3 | -0.42 USD | -13.51% |
| 2021 Q2 | -0.37 USD | -136.63% |
| 2021 FY | - USD | -22.22% |
| 2021 Q1 | 1.01 USD | 1153.18% |
| 2021 Q4 | -0.84 USD | -100.0% |
| 2020 FY | - USD | 40.0% |
| 2020 Q2 | -0.42 USD | 70.83% |
| 2020 Q3 | -0.37 USD | 11.9% |
| 2020 Q4 | -0.10 USD | 74.08% |
| 2020 Q1 | -1.44 USD | -1007.69% |
| 2019 FY | - USD | -748.65% |
| 2019 Q4 | -0.13 USD | 82.43% |
| 2019 Q1 | -0.82 USD | -3.8% |
| 2019 Q2 | -0.59 USD | 28.05% |
| 2019 Q3 | -0.74 USD | -25.42% |
| 2018 Q4 | -0.79 USD | -11.27% |
| 2018 Q3 | -0.71 USD | -317.65% |
| 2018 FY | - USD | 102.07% |
| 2018 Q1 | 2.00 USD | 118.2% |
| 2018 Q2 | -0.17 USD | -108.5% |
| 2017 Q1 | -1.04 USD | -204.0% |
| 2017 FY | - USD | -344.79% |
| 2017 Q4 | -10.99 USD | -144.77% |
| 2017 Q3 | -4.49 USD | -223.02% |
| 2017 Q2 | -1.39 USD | -33.65% |
| 2016 Q1 | 6.00 USD | 1900.0% |
| 2016 Q4 | 1.00 USD | 814.29% |
| 2016 Q3 | -0.14 USD | -128.0% |
| 2016 FY | - USD | -35.4% |
| 2016 Q2 | 0.50 USD | -91.67% |
| 2015 Q2 | 0.60 USD | 50.0% |
| 2015 FY | - USD | 769.23% |
| 2015 Q4 | 0.30 USD | -96.97% |
| 2015 Q1 | 0.40 USD | 0.0% |
| 2015 Q3 | 9.90 USD | 1550.0% |
| 2014 Q1 | -0.08 USD | -119.97% |
| 2014 Q2 | 0.40 USD | 600.63% |
| 2014 FY | - USD | 1200.0% |
| 2014 Q4 | 0.40 USD | -33.33% |
| 2014 Q3 | 0.60 USD | 50.0% |
| 2013 Q2 | -0.32 USD | 75.38% |
| 2013 FY | - USD | 103.85% |
| 2013 Q4 | 0.40 USD | -71.43% |
| 2013 Q3 | 1.40 USD | 537.5% |
| 2013 Q1 | -1.30 USD | -35.42% |
| 2012 FY | - USD | -48.57% |
| 2012 Q3 | -0.47 USD | -2.17% |
| 2012 Q2 | -0.46 USD | 30.3% |
| 2012 Q1 | -0.66 USD | 55.1% |
| 2012 Q4 | -0.96 USD | -104.26% |
| 2011 Q1 | -0.20 USD | 33.33% |
| 2011 FY | - USD | 47.13% |
| 2011 Q4 | -1.47 USD | -1570.0% |
| 2011 Q3 | 0.10 USD | 183.33% |
| 2011 Q2 | -0.12 USD | 40.0% |
| 2010 FY | - USD | -1203.33% |
| 2010 Q1 | -0.66 USD | -430.0% |
| 2010 Q4 | -0.30 USD | 57.75% |
| 2010 Q3 | -0.71 USD | 56.97% |
| 2010 Q2 | -1.65 USD | -150.0% |
| 2009 FY | - USD | 108.29% |
| 2009 Q2 | 0.40 USD | 763.93% |
| 2009 Q3 | -0.22 USD | -155.0% |
| 2009 Q1 | 0.05 USD | 102.56% |
| 2009 Q4 | 0.20 USD | 190.91% |
| 2008 Q1 | -0.74 USD | -27.59% |
| 2008 Q2 | -0.61 USD | 17.57% |
| 2008 Q3 | -0.46 USD | 24.59% |
| 2008 Q4 | -1.81 USD | -293.48% |
| 2008 FY | - USD | -395.89% |
| 2007 Q4 | -0.58 USD | -87.1% |
| 2007 Q1 | 0.08 USD | 199.24% |
| 2007 Q2 | 0.10 USD | 27.06% |
| 2007 FY | - USD | 78.21% |
| 2007 Q3 | -0.31 USD | -410.0% |
| 2006 Q2 | -0.64 USD | 57.33% |
| 2006 Q3 | -1.14 USD | -78.12% |
| 2006 FY | - USD | 35.7% |
| 2006 Q1 | -1.50 USD | -1.35% |
| 2006 Q4 | -0.08 USD | 93.04% |
| 2005 Q3 | -1.51 USD | 9.04% |
| 2005 Q4 | -1.48 USD | 1.99% |
| 2005 FY | - USD | -5310.0% |
| 2005 Q1 | -0.54 USD | -2340.66% |
| 2005 Q2 | -1.66 USD | -207.41% |
| 2004 Q4 | 0.02 USD | -87.95% |
| 2004 Q2 | 0.26 USD | 100.32% |
| 2004 FY | - USD | 100.01% |
| 2004 Q3 | 0.20 USD | -23.08% |
| 2004 Q1 | -81.58 USD | 0.0% |
| 2003 Q2 | -570.52 USD | 16.53% |
| 2003 Q1 | -683.50 USD | 0.0% |
| 2003 FY | - USD | 72.74% |
| 2002 FY | - USD | 35.86% |
| 2001 FY | - USD | -47.75% |
| 2000 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -1.27 USD | 684.252% |
| Applied DNA Sciences, Inc. | -15.21 USD | 148.784% |
| Aspira Women's Health Inc. | -1.81 USD | 509.945% |
| Biodesix, Inc. | -0.64 USD | 1259.375% |
| BioNexus Gene Lab Corp. | -0.17 USD | 4464.706% |
| bioAffinity Technologies, Inc. | -0.91 USD | 915.385% |
| bioAffinity Technologies, Inc. | -0.91 USD | 915.385% |
| Bionano Genomics, Inc. | -6.81 USD | 208.957% |
| CareDx, Inc | -3.54 USD | 309.605% |
| Check-Cap Ltd. | -3.00 USD | 347.333% |
| Castle Biosciences, Inc. | -2.14 USD | 446.729% |
| DarioHealth Corp. | -1.93 USD | 484.456% |
| Exact Sciences Corporation | -1.13 USD | 756.637% |
| Fulgent Genetics, Inc. | -5.63 USD | 231.794% |
| Guardant Health, Inc. | -4.28 USD | 273.364% |
| ICON Public Limited Company | 7.46 USD | 0.536% |
| IDEXX Laboratories, Inc. | 10.17 USD | 27.04% |
| Illumina, Inc. | -7.35 USD | 200.952% |
| Intelligent Bio Solutions Inc. | -6.38 USD | 216.301% |
| iSpecimen Inc. | -1.23 USD | 703.252% |
| Standard BioTools Inc. | -0.94 USD | 889.362% |
| MDxHealth SA | -1.66 USD | 546.988% |
| 23andMe Holding Co. | -1.40 USD | 630.0% |
| Medpace Holdings, Inc. | 9.20 USD | 19.348% |
| Myriad Genetics, Inc. | -1.39 USD | 633.813% |
| Mainz Biomed B.V. | -1.62 USD | 558.025% |
| ENDRA Life Sciences Inc. | -1.11 USD | 768.468% |
| NeoGenomics, Inc. | -0.70 USD | 1160.0% |
| Neogen Corporation | -0.04 USD | 17157.471% |
| Inotiv, Inc. | -4.10 USD | 280.976% |
| Natera, Inc. | -3.78 USD | 296.296% |
| OpGen, Inc. | -41.47 USD | 117.892% |
| OPKO Health, Inc. | -0.25 USD | 3068.0% |
| Psychemedics Corporation | -0.72 USD | 1130.556% |
| Prenetics Global Limited | -5.58 USD | 232.975% |
| Prenetics Global Limited | -5.58 USD | 232.975% |
| Precipio, Inc. | -4.51 USD | 264.523% |
| Personalis, Inc. | -2.25 USD | 429.778% |
| RadNet, Inc. | 0.05 USD | -15390.605% |
| Sera Prognostics, Inc. | -1.16 USD | 739.655% |
| Sotera Health Company | 0.18 USD | -4022.222% |
| Neuronetics, Inc. | -1.05 USD | 806.667% |
| Star Equity Holdings, Inc. | 7.42 USD | 0.0% |
| Trinity Biotech plc | -3.14 USD | 336.306% |
| T2 Biosystems, Inc. | -19.19 USD | 138.666% |
| Twist Bioscience Corporation | -3.60 USD | 306.111% |
| Exagen Inc. | -1.34 USD | 653.731% |